ImageneBio, Inc.
IMA
$5.84
-$0.03-0.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 200.00% | 122.07% | 119.47% | 568.44% | -10.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.15% | 77.76% | 38.46% | 380.38% | 15.24% |
| Operating Income | -60.15% | -101.48% | -38.46% | -1,206.19% | -15.24% |
| Income Before Tax | -33.97% | -74.58% | -49.70% | -680.80% | -21.19% |
| Income Tax Expenses | -- | -- | -2,223.08% | -- | -- |
| Earnings from Continuing Operations | -34.19% | -74.74% | -43.56% | -678.48% | -21.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.19% | -74.74% | -43.56% | -678.48% | -21.19% |
| EBIT | -60.15% | -101.48% | -38.46% | -1,206.19% | -15.24% |
| EBITDA | -58.84% | -99.89% | -32.45% | -1,255.35% | -23.92% |
| EPS Basic | 85.88% | 75.05% | -3,534.12% | -- | -- |
| Normalized Basic EPS | 80.05% | 62.53% | -6,078.46% | -- | -- |
| EPS Diluted | 85.88% | 75.05% | -3,534.12% | -- | -- |
| Normalized Diluted EPS | 80.05% | 62.53% | -6,078.46% | -- | -- |
| Average Basic Shares Outstanding | 571.59% | 366.21% | -97.58% | -- | -- |
| Average Diluted Shares Outstanding | 571.59% | 366.21% | -97.58% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |